Patents by Inventor Ajay Maghodia

Ajay Maghodia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230091932
    Abstract: The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a target sequence. In some embodiments, the first ITR and/or the second ITR is an ITR of human bocavirus. Also disclosed are methods of using the nucleic acid molecules in gene therapy applications.
    Type: Application
    Filed: August 22, 2022
    Publication date: March 23, 2023
    Inventors: Ajay Maghodia, Christian Mueller, Tongyao Liu
  • Publication number: 20230084036
    Abstract: The present disclosure provides codon optimized Factor VIII sequences, vectors, and host cells comprising codon optimized Factor VIII sequences, polypeptides encoded by codon optimized Factor VIII sequences, and methods of producing such polypeptides.
    Type: Application
    Filed: August 22, 2022
    Publication date: March 16, 2023
    Inventors: Ajay Maghodia, Tongyao Liu, Philip Zakas
  • Publication number: 20230059552
    Abstract: The current teachings are directed to novel virus free cells lines derived from virus-contaminated staring material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: novel cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the novel cell lines lack Sf-rhabdovirus; and novel cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the novel cell line lacks an alphanodavirus.
    Type: Application
    Filed: September 12, 2022
    Publication date: February 23, 2023
    Inventors: Ajay Maghodia, Christoph Geisler, Donald Jarvis
  • Publication number: 20220356490
    Abstract: Provided herein is a baculovirus expression vector system for the production of a desired protein. In one aspect, the desired protein is a closed-ended DNA (ceDNA) molecule comprising wild-type and/or truncated inverted terminal repeats derived from a genome of a member of the viral family Parvoviridae.
    Type: Application
    Filed: January 14, 2022
    Publication date: November 10, 2022
    Inventors: Tongyao Liu, Ajay Maghodia, Philip Zakas
  • Patent number: 11473055
    Abstract: The current teachings are directed to virus free cells lines derived from virus-contaminated starting material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the cell lines lack Sf-rhabdovirus; and cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the cell line lacks an alphanodavirus.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: October 18, 2022
    Assignee: GLYCOBAC, LLC
    Inventors: Ajay Maghodia, Christoph Geisler, Donald Jarvis
  • Publication number: 20220243201
    Abstract: The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a target sequence. In some embodiments, the first ITR and/or the second ITR is an ITR of a non-adeno-associated virus (AAV). Also disclosed are methods of using the nucleic acid molecules in gene therapy applications.
    Type: Application
    Filed: January 14, 2022
    Publication date: August 4, 2022
    Inventors: Ajay Maghodia, Philip Zakas
  • Publication number: 20220090130
    Abstract: The present disclosure relates to a recombinant baculovirus expression vector (rBEV) for the production of closed-ended DNA (ceDNA) in insect cells.
    Type: Application
    Filed: August 23, 2021
    Publication date: March 24, 2022
    Inventor: Ajay Maghodia
  • Publication number: 20180355311
    Abstract: The current teachings are directed to novel virus free cells lines derived from virus-contaminated staring material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: novel cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the novel cell lines lack Sf-rhabdovirus; and novel cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the novel cell line lacks an alphanodavirus.
    Type: Application
    Filed: November 1, 2016
    Publication date: December 13, 2018
    Applicant: Glycobac, LLC
    Inventors: Ajay Maghodia, Christoph Geisler, Donald Jarvis